Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: A case report

Majd D. Jawad; Ronald S. Go; Rhett P. Ketterling; Kebede H. Begna; Kaaren K. Reichard; Min Shi

doi:10.1002/ccr3.506

Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: A case report

Majd D. Jawad, Ronald S. Go, Rhett P. Ketterling, Kebede H. Begna, Kaaren K. Reichard, Min Shi

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Tyrosine kinase inhibitor treated chronic myelogenous leukemia patients with monosomy 7 arising in Philadelphia chromosome negative (Ph-) cells tend to evolve into MDS/AML. However, monosomy 7 in Ph- cells can be a transient finding, and it is not an absolute indication of the emergence of a new myeloid malignancy.

Original language	English (US)
Pages (from-to)	282-286
Number of pages	5
Journal	Clinical Case Reports
Volume	4
Issue number	3
DOIs	https://doi.org/10.1002/ccr3.506
State	Published - Mar 1 2016

Keywords

Chronic myelogenous leukemia
Monosomy 7

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1002/ccr3.506

Cite this

@article{af6e999d5edf45aeba09970a6cbfb120,

title = "Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: A case report",

abstract = "Tyrosine kinase inhibitor treated chronic myelogenous leukemia patients with monosomy 7 arising in Philadelphia chromosome negative (Ph-) cells tend to evolve into MDS/AML. However, monosomy 7 in Ph- cells can be a transient finding, and it is not an absolute indication of the emergence of a new myeloid malignancy.",

keywords = "Chronic myelogenous leukemia, Monosomy 7",

author = "Jawad, {Majd D.} and Go, {Ronald S.} and Ketterling, {Rhett P.} and Begna, {Kebede H.} and Reichard, {Kaaren K.} and Min Shi",

note = "Publisher Copyright: {\textcopyright} 2016 John Wiley & Sons Ltd.",

year = "2016",

month = mar,

day = "1",

doi = "10.1002/ccr3.506",

language = "English (US)",

volume = "4",

pages = "282--286",

journal = "Clinical Case Reports",

issn = "2050-0904",

publisher = "John Wiley and Sons Ltd",

number = "3",

}

TY - JOUR

T1 - Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy

T2 - A case report

AU - Jawad, Majd D.

AU - Go, Ronald S.

AU - Ketterling, Rhett P.

AU - Begna, Kebede H.

AU - Reichard, Kaaren K.

AU - Shi, Min

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Tyrosine kinase inhibitor treated chronic myelogenous leukemia patients with monosomy 7 arising in Philadelphia chromosome negative (Ph-) cells tend to evolve into MDS/AML. However, monosomy 7 in Ph- cells can be a transient finding, and it is not an absolute indication of the emergence of a new myeloid malignancy.

AB - Tyrosine kinase inhibitor treated chronic myelogenous leukemia patients with monosomy 7 arising in Philadelphia chromosome negative (Ph-) cells tend to evolve into MDS/AML. However, monosomy 7 in Ph- cells can be a transient finding, and it is not an absolute indication of the emergence of a new myeloid malignancy.

KW - Chronic myelogenous leukemia

KW - Monosomy 7

UR - http://www.scopus.com/inward/record.url?scp=85033198604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033198604&partnerID=8YFLogxK

U2 - 10.1002/ccr3.506

DO - 10.1002/ccr3.506

M3 - Article

AN - SCOPUS:85033198604

SN - 2050-0904

VL - 4

SP - 282

EP - 286

JO - Clinical Case Reports

JF - Clinical Case Reports

IS - 3

ER -

Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: A case report

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this